1. Cyclooxygenase-2 Inhibition with Celecoxib Delays Tumor Growth in an Orthotopic Murine Model of Cholangiocarcinoma – A Novel Therapeutic Strategy for Cholangiocarcinoma. (2022) Authors: Dave, Y.; Burchard, P.; Chacon, A.; Ruffolo, L.; Ullman, N.; Georger, M.; Jewell, R.; Belt, B.; Hernandez Alejandro, R.; Linehan, D. Journal: HPB Issue: Volume 24(2022)Supplement 1 Page Start: S456 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Early Postoperative ERAS Compliance is Associated with Decreased Length of Stay and Complications Following Liver Resection. (2022) Authors: Burchard, P.; Dave, Y.; Loria, A.; Parikh, N.; Pineda-Solis, K.; Strawderman, M.; Schoeniger, L.; Galka, E.; Tomiyama, K.; Orloff, M.; Carpizo, D.; Linehan, D.; Hernandez-Alejandro, R. Journal: HPB Issue: Volume 24(2022)Supplement 1 Page Start: S168 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Pan-Lysyl Oxidase Inhibition with PXS-5505 Improves Survival and Decreases Activated Fibroblast Density in a Mouse Model of Cholangiocarcinoma. (2022) Authors: Burchard, P.; Ruffolo, L.; Ullman, N.; Dave, Y.; Georger, M.; Jewell, R.; Belt, B.; Linehan, D.; Hernandez-Alejandro, R. Journal: HPB Issue: Volume 24(2022)Supplement 1 Page Start: S58 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗